LONDON, United Kingdom, 06th February, 2024 — Sixfold Bioscience, a leading AI-enabled RNA delivery company, today announced their upcoming presentation at the SLAS2024, Boston.
SLAS is a global, non-profit professional community made up of scientists from academia, government and industry who are collectively focused on leveraging the power of technology to achieve scientific objectives.
Sixfold Bioscience team lead of Structure & Characterization, Dr. Alice Ghidini, will be presenting her talk on “‘Revolutionizing RNA Delivery: Harnessing the Body's Evolved Transport Pathways” in the 'Innovations in Analytical Techniques and Biophysical Tools for Biomolecular Characterization' session at 9.30 am EST on Wednesday 7th of February.
[Page updated, 22nd Feb, to include photo below]
Sixfold Biosciences is a biotechnology company solving one of the most critical challenges preventing the greater utilization of powerful RNA medicines: delivery. Sixfold’s solution takes evolution as inspiration, learning and mimicking how RNA is naturally delivered to different cell types in the body. Using advanced AI and Bayesian Optimization, Sixfold is learning the language that encodes RNA-shuttle interactions and destination selection, unlocking new cell types for treatment.
Sixfold to present at the 5th Nordic Nucleic Acid Based Medicine Industry Network Meeting
September 12, 2024
Read moreSixfold Bioscience Present Research on Generative Modeling Platform at ICML 2024
July 26, 2024
Read moreGenerative Machine Learning enabled RNA delivery receives UKRI funding.
July 23, 2024
Read more